Hikma Pharmaceutical | HIK - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
Almirall EUR 30.32M 22M 2025-12
argenx SE USD 426M 22.71M 2026-03
AstraZeneca USD 4.81B 894M 2026-06
Autolus Therapeutics Ltd USD -91.52M 12.93M 2025-12
Bayer EUR -3.37B 2.21B 2025-12
Fresenius EUR 601M 122M 2025-12
Genmab DKK 55M 427M 2025-12
GlaxoSmithKline GBP 2.68B 532M 2026-06
GRIFOLS EUR 112M 78.51M 2026-03
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Lonza CHF 624M 197M 2024-12
Merck EUR 401M 886.1M 2025-12
Orion EUR 113.4M 213.6M 2026-03
Recordati EUR 200.75M 48.78M 2026-03
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR -1.16B 5.5B 2025-12
UCB EUR 789M 427M 2025-06